UnitedHealth Group Inc (UNH) Shares Bought by Patten & Patten Inc. TN

Patten & Patten Inc. TN increased its holdings in UnitedHealth Group Inc (NYSE:UNH) by 95.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,107 shares of the healthcare conglomerate’s stock after buying an additional 9,828 shares during the period. Patten & Patten Inc. TN’s holdings in UnitedHealth Group were worth $4,433,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. BlackRock Inc. boosted its position in shares of UnitedHealth Group by 1.2% in the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after buying an additional 796,654 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after buying an additional 1,588,516 shares in the last quarter. FMR LLC boosted its position in shares of UnitedHealth Group by 2.1% in the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after buying an additional 1,168,324 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of UnitedHealth Group by 2.3% in the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after buying an additional 174,290 shares in the last quarter. Finally, TIAA CREF Investment Management LLC boosted its position in shares of UnitedHealth Group by 3.9% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after buying an additional 223,524 shares in the last quarter. Institutional investors and hedge funds own 85.65% of the company’s stock.

UNH has been the topic of several recent research reports. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 27th. Evercore ISI reiterated an “outperform” rating and issued a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective on the stock in a research report on Saturday, January 20th. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Finally, ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Two investment analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $243.22.

In other news, Director Michele J. Hooper sold 10,000 shares of the company’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the transaction, the director now owns 37,284 shares of the company’s stock, valued at approximately $8,864,643.84. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Michele J. Hooper sold 5,000 shares of the company’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 53,396 shares of company stock valued at $12,262,067. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Inc (NYSE UNH) opened at $230.16 on Friday. UnitedHealth Group Inc has a one year low of $161.74 and a one year high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. The company has a market cap of $222,720.00, a PE ratio of 24.23, a PEG ratio of 1.32 and a beta of 0.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter in the prior year, the company posted $2.11 EPS. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. sell-side analysts forecast that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.58%.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/25/unitedhealth-group-inc-unh-shares-bought-by-patten-patten-inc-tn.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply